Investing Profile

Beat Steffen

VCInvestor
Principal Novartis Venture Fund at Novartis
nvfund.comBasel, Switzerland
Photo of Beat Steffen, Principal at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Mckinsey & Company Network
309 CONNECTIONS
INSEAD Network
156 CONNECTIONS
Novartis Network
53 CONNECTIONS
cb
$5.0M - $10.0M
$7.5M
3
$750M
CompanyStageDateRound SizeTotal Raised
Splice Bio
Series BJun 2025$140M
Series AFeb 2022$57M
$190M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Joël Jean-Mairet (Ysios Capital), Daniela Begolo (INKEF Capital), Laia Crespo (Sanofi Ventures), Carole Nuechterlein (F.Hoffmann-La Roche), Sylvain Sachot (Asabys Partners)
Rappta Therapeutics
Series AOct 2020$11M
$11M
Co-investors: Raj Parekh (Advent Life Sciences)
Resident in Cardiovascular Surgery HotmailPresent
Senior Associate Mckinsey & CompanyPresent
Regional Director West CV Specialty Sales NovartisPresent
Associate Director Valturna NovartisPresent
Head Marketing General Medicines NovartisPresent
Assistant to Head of Pharma Division NovartisPresent
General Manager Serelaxin NovartisPresent
Global Franchise Head Critical Care ai NovartisPresent
Principal Novartis Venture Fund NovartisPresent
Member Board of Directors HotmailPresent
Member Board of Directors Binx HealthPresent
Member Board of Directors Vivet TherapeuticsPresent
Chairman of the Board UZH Life Sciences FundPresent
Chairman of the Board Rappta TherapeuticsPresent
Managing Director Novartis Venture Fund NovartisPresent
Member Board of Directors SpliceBioPresent
Universität Zürich | University of Zurich Medical Doctor Medicine
INSEAD MBA Finance